Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.24.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Cash and cash equivalents $ 289,000 $ 7,609,000
Accounts receivable 4,515,000 8,287,000
Prepaid expense and other current assets 782,000 862,000
Total current assets 5,586,000 16,758,000
Property and equipment, net 37,000 70,000
Intangible assets, net 4,698,000 6,636,000
Goodwill 1,864,000 1,864,000
Other receivable – noncurrent 395,000 0
Total assets 12,580,000 25,328,000
Accounts payable and accrued expenses 5,927,000 10,420,000
Accrued contingent consideration 268,000 1,812,000
Promissory note - contingent consideration 1,765,000 0
Contract liabilities 154,000 339,000
Secured loan – SLR Facility 0 800,000
Total current liabilities 8,114,000 13,371,000
Accrued contingent consideration – noncurrent 0 396,000
Warrant liability 947,000 1,571,000
Total liabilities 9,061,000 15,338,000
Commitments and Contingencies  
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 20,592 and 23,656 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. 0 0
Common stock, par value $0.001 per share; 400,000,000 shares authorized; 11,714,087 and 4,774,116 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. 89,000 81,000
Additional paid-in capital 267,081,000 258,923,000
Accumulated deficit (263,651,000) (249,014,000)
Total stockholders’ equity 3,519,000 9,990,000
Total liabilities and stockholders’ equity $ 12,580,000 $ 25,328,000